Invivyd IVVD
NASDAQ IVVD
$0.61 -0.03 (-4.74%)
As of: Oct 22, 2026 · 12:31 PM EDT

Invivyd (IVVD) Net Margin (2024 - 2026)

Updated

Invivyd (IVVD) recorded Net Margin of -310.77% in Q2 2026, down 186.38 percentage points from -124.38% a year earlier.

Analysis

Invivyd (IVVD) Net Margin (2024 - 2026) Analysis & Trends

On a TTM basis, Invivyd's Net Margin came in at -142.90% as of Jun 30, 2026, up 95.43 percentage points year-over-year; for FY2025, it was -98.27%, up 571.15 percentage points from FY2024.

  • Across earlier years, Net Margin came in at -669.42% in FY2024.
  • The Q2 2026 figure is the lowest quarterly Net Margin since Q3 2024.
  • On a year-over-year basis, Net Margin rose in three of the last four quarters, with an average year-over-year change of +604.63 percentage points.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,174.91 Bn 1,143.49 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 644.40 Bn 562.93 Bn 17.26 Bn 21.86%
3 AbbVie 503.86 Bn 476.97 Bn 12.70 Bn 21.27%
4 Merck 379.74 Bn 334.12 Bn 12.21 Bn -8.04%
5 Novartis Ag 303.49 Bn 267.48 Bn 11.24 Bn 22.65%
6 Astrazeneca 269.36 Bn 243.04 Bn 12.86 Bn 16.30%
7 Amgen 243.43 Bn 198.83 Bn 7.24 Bn 23.62%
8 Gilead Sciences 194.04 Bn 168.24 Bn 6.22 Bn -134.51%
9 Pfizer 172.94 Bn 119.58 Bn 10.94 Bn -1.65%
10 Invivyd 195.08 Mn -311.56 Mn 13.01 Mn -310.77%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -310.77%
Dec 31, 2025 -64.40%
Sep 30, 2025 -79.75%
Jun 30, 2025 -124.38%
Mar 31, 2025 -144.10%
Dec 31, 2024 -133.45%
Sep 30, 2024 -653.11%
Jun 30, 2024 -2,086.88%
API Access

Invivyd Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=IVVD&period=max&api_key=YOUR_API_KEY